Corvex (MOVE) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
4 Sep, 2026Company overview and business model
Operates as an AI cloud computing platform focused on secure, scalable, and cost-efficient GPU-accelerated infrastructure for AI workloads.
Offers AI Factories, GPU Clusters, confidential computing, and Token Factory (in alpha), targeting enterprise and security-conscious customers.
Provides managed Kubernetes, bare metal, and HIPAA/SOC 2 compliant deployments.
Recent merger completed in March 2026, resulting in a name change and expanded capabilities.
Financial performance and metrics
Reported net loss of $18.3 million for 2025, improved from $23.7 million in 2024 (as adjusted for stock dividend).
Weighted average shares used in computing net loss per share increased to 1,141,699 in 2025 from 817,970 in 2024.
Stock dividend of 0.358 shares per share outstanding was distributed in April 2026, effectively a 1.358-for-1 stock split.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for working capital and general corporate purposes, including infrastructure expansion and commercialization activities.
Latest events from Corvex
- Rapidly scaling AI infrastructure platform with proprietary security and strong growth pipeline.MOVE
Investor presentation - Q2 2026 revenue was $3.8M, net loss $(12.8)M, and live compute ARR reached $22M.MOVE
Q2 2026 - AI cloud platform registers 53.4M shares for resale, with no new capital raised and high dilution risk.MOVE
Registration filing - All proposals, including board expansion and stock plans, were approved as the company pivots to AI.MOVE
AGM 2026 - Shareholders to approve director elections, share issuances, equity plans, and auditor after a major merger.MOVE
Proxy filing - Proxy seeks approval for merger-related equity, new plans, and board elections, with full board support.MOVE
Proxy filing - Q1 2026 revenue rose 148% to $510K, with pro forma revenue at $3.7M after the AI-focused merger.MOVE
Q1 2026 - Merger completed, AI focus established, healthcare sales paused, FY2025 net loss $18.3M on $0.4M revenue.MOVE
Q4 2025 - 2024 revenue grew to $1.0M, but ongoing losses and cash needs raise going concern risks.MOVE
Q4 2024